Literature DB >> 21635900

Two-intermediate model to characterize the structure of fast-folding proteins.

I Roterman1, L Konieczny, W Jurkowski, K Prymula, M Banach.   

Abstract

This paper introduces a new model that enables researchers to conduct protein folding simulations. A two-step in silico process is used in the course of structural analysis of a set of fast-folding proteins. The model assumes an early stage (ES) that depends solely on the backbone conformation, as described by its geometrical properties--specifically, by the V-angle between two sequential peptide bond planes (which determines the radius of curvature, also called R-radius, according to a second-degree polynomial form). The agreement between the structure under consideration and the assumed model is measured in terms of the magnitude of dispersion of both parameters with respect to idealized values. The second step, called late-stage folding (LS), is based on the "fuzzy oil drop" model, which involves an external hydrophobic force field described by a three-dimensional Gauss function. The degree of conformance between the structure under consideration and its idealized model is expressed quantitatively by means of the Kullback-Leibler entropy, which is a measure of disparity between the observed and expected hydrophobicity distributions. A set of proteins, representative of the fast-folding group - specifically, cold shock proteins - is shown to agree with the proposed model.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2011        PMID: 21635900     DOI: 10.1016/j.jtbi.2011.05.027

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  12 in total

1.  Internal force field in proteins seen by divergence entropy.

Authors:  Damian Marchewka; Mateusz Banach; Irena Roterman
Journal:  Bioinformation       Date:  2011-07-06

2.  Statistical dictionaries for hypothetical in silico model of the early-stage intermediate in protein folding.

Authors:  Barbara Kalinowska; Piotr Fabian; Katarzyna Stąpor; Irena Roterman
Journal:  J Comput Aided Mol Des       Date:  2015-03-26       Impact factor: 3.686

3.  iGPCR-drug: a web server for predicting interaction between GPCRs and drugs in cellular networking.

Authors:  Xuan Xiao; Jian-Liang Min; Pu Wang; Kuo-Chen Chou
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

4.  Structural Interface Forms and Their Involvement in Stabilization of Multidomain Proteins or Protein Complexes.

Authors:  Jacek Dygut; Barbara Kalinowska; Mateusz Banach; Monika Piwowar; Leszek Konieczny; Irena Roterman
Journal:  Int J Mol Sci       Date:  2016-10-18       Impact factor: 5.923

5.  Towards the design of anti-amyloid short peptide helices.

Authors:  Irena Roterman; Mateusz Banach; Leszek Konieczny
Journal:  Bioinformation       Date:  2018-01-31

6.  Structure of the Hydrophobic Core Determines the 3D Protein Structure-Verification by Single Mutation Proteins.

Authors:  Mateusz Banach; Piotr Fabian; Katarzyna Stapor; Leszek Konieczny; And Irena Roterman
Journal:  Biomolecules       Date:  2020-05-14

7.  Contingency Table Browser - prediction of early stage protein structure.

Authors:  Barbara Kalinowska; Artur Krzykalski; Irena Roterman
Journal:  Bioinformation       Date:  2015-10-31

8.  Hypothetical in silico model of the early-stage intermediate in protein folding.

Authors:  Barbara Kalinowska; Paweł Alejster; Kinga Sałapa; Zbigniew Baster; Irena Roterman
Journal:  J Mol Model       Date:  2013-06-28       Impact factor: 1.810

9.  iEzy-drug: a web server for identifying the interaction between enzymes and drugs in cellular networking.

Authors:  Jian-Liang Min; Xuan Xiao; Kuo-Chen Chou
Journal:  Biomed Res Int       Date:  2013-11-26       Impact factor: 3.411

10.  Different Synergy in Amyloids and Biologically Active Forms of Proteins.

Authors:  Piotr Fabian; Katarzyna Stapor; Mateusz Banach; Magdalena Ptak-Kaczor; Leszek Konieczny; Irena Roterman
Journal:  Int J Mol Sci       Date:  2019-09-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.